Answers are grounded in this paper and cite their sources.
Cohort study finds adjuvant chemotherapy fails to improve overall survival in older adults with stage II colon cancer, indicating routine use may not benefit this population.
Among Medicare patients identified with stage II colon cancer, either with or without poor prognostic features, adjuvant chemotherapy did not substantially improve overall survival. This lack of benefit must be considered in treatment decisions for similar older adults with colon cancer.
No takes yet. Share an insight, caveat, or question.
O’Connor et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: